Webinars

Home » Webinars

June 14th 2018 WEBINAR – What’s so different about QBECO? Why it’s unlike any other biologic.

The RESTORE clinical trial is currently recruiting participants to study QBECO SSI in adults with moderate to severe Crohn’s disease.

Join Qu Biologics’ Director of Scientific Innovation, Shirin Kalyan and Director of Preclinical Research Dr. Mark Bazett, for an exciting and informative webinar on Thursday June 14th 2018 at 4:00 PM Pacific time (7:00 PM Eastern time). Simply write “Webinar” in the subject line then email us at info@quibd.com. We’ll add you to our registration list and send you the log-in details.

Drs. Kalyan and Bazett will be discussing the science behind Qu’s approach to immune therapy and how it is radically different from the way current commercially available biologics work. There will be lots of time after the presentation for your questions. Register now! Simply write “Webinar” in the subject line then email us at info@quibd.com.

RESTORE clinical trial webinar – Meet the Trial Recruitment nurse and past participants. May 17th 2018

In this webinar, broadcast on May 17th 2018, Qu Biologics’ VP of Clinical Operations Jim Pankovich described Qu’s SSI technology, gave a brief study outline and introduced the Clinical Trial Recruitment nurse. We also heard from 2 past clinical trial participants who received QBECO SSI for IBD and described their experiences.

 

QBECO SSI for remission in adults with moderate to severe Crohn’s disease – Trial sites and participation details. April 5th 2018

In this webinar, broadcast on April 5th 2018, Dr. Hal Gunn outlines specifics about Qu Biologics’ latest clinical trial of QBECO SSI for remission in adults with moderate to severe Crohn’s disease. He discusses the study site locations and participation details as well as answering questions posed by the online audience.

 

A study of QBECO SSI for remission in adults with moderate to severe Crohn’s disease. March 5th 2018

In this webinar, first broadcast on March 5th 2018, Dr. Hal Gunn talks about Qu Biologics’ latest clinical trial, testing QBECO SSI for remission in adults with moderate to severe Crohn’s disease. He discusses the study design, participation essentials as well as answering questions posed by the online audience.